商標ウォッチ

公開日2025-01-08
公報種別公開国際商標公報
国際登録番号1819230
国際登録日2023-11-21
区分第35類(広告・事務),第42類(科学・技術),第44類(医療・農林業),第45類(法律)
商品役務Business consulting services; consulting services in the field of patient relationship management for healthcare providers (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); data processing services in the field of healthcare, namely, curation, de-identification, and enrichment of healthcare, medical, clinical, and patient data; recruitment and placement of volunteers in the field of clinical studies, namely, recruiting and placing patients for participation in clinical studies for the testing of drugs, testing of medical devices, and diagnostic research; business data analysis services in the field of healthcare, medical, clinical, and patient data; business consulting and management in the field of clinical trials; collecting and analyzing claims data from healthcare organizations for business purposes; commercial administration of the licensing of healthcare, biotechnology, and clinical data of others; recruitment advertisement services, namely 全 56 件を表示, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; collection of data; compiling data for research purposes in the field of medical science and medical consultancy.,Innovation consulting services, namely, advising others in the areas of product development; platform as a service (PaaS) featuring computer software platforms for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; platform as a service (PaaS) featuring computer software platforms for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; platform as a service (PaaS) featuring computer software platforms for providing access to an electronic exchange of medical records across a nationwide health information network; software as a service (SaaS) services featuring software for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; software as a service (SaaS) services featuring software for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; software as a service (SaaS) services featuring software for providing access to an electronic exchange of medical records across a nationwide health information network; providing an on-line searchable database in the field of healthcare, medical, clinical, and patient data for scientific research purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).,Consulting services in the field of healthcare; health care services, namely, providing a database in the field of biotechnology, neurology, cardiology, oncology and rare diseases information and featuring inputting and collection of information all for treatment and diagnostic purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); remote monitoring of medical data for medical diagnosis and treatment.,Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval.
基礎出願番号98253910
基礎出願日2023-11-03
基礎出願国US
出願人Graticule, Inc.
OCRテキストGRATICULP
OCRテキスト2GRATICULE
OCRについて

関連商標